Product NDC: | 55390-013 |
Proprietary Name: | Dihydroergotamine Mesylate |
Non Proprietary Name: | Dihydroergotamine Mesylate |
Active Ingredient(s): | 1 mg/mL & nbsp; Dihydroergotamine Mesylate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-013 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040453 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030904 |
Package NDC: | 55390-013-10 |
Package Description: | 10 VIAL in 1 BOX (55390-013-10) > 1 mL in 1 VIAL |
NDC Code | 55390-013-10 |
Proprietary Name | Dihydroergotamine Mesylate |
Package Description | 10 VIAL in 1 BOX (55390-013-10) > 1 mL in 1 VIAL |
Product NDC | 55390-013 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dihydroergotamine Mesylate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20030904 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DIHYDROERGOTAMINE MESYLATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |